Table 5.

Results of in-vivo pharmacokinetic properties after oral delivery of CIP and HA-CIP SNEDDS to mice.

Parameter	Unit	CIP	HA-CIP
t1/2	H	4 ± 1.57	16 ± 3.57
T max	H	1 ± 3.37	3 ± 3.12
C max	μg/mL	54.50 ± 2.57	225.65 ± 3.89
AUC 0-t	μg/mL × h	210.75 ± 3.59	1562.83 ± 1.23
AUC 0-inf	μg/mL × h	600.84 ± 2.17	2124.50 ± 1.90
AUMC 0-inf	μg/mL × h2	900.65 ± 1.57	36,794.5 ± 2.68